300841 康华生物
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资6,3530.00%6,3536,50000
投资性房地产0--0000
固定资产938,121-1.86%955,906849,035461,656248,517
在建工程2,760-9.24%3,041112,254523,346238,714
无形资产16,503-5.77%17,51415,37617,23318,766
商誉0--0000
其他非流动资产565,6571.60%556,768569,205563,729569,457
1,529,393-0.66%1,539,5811,552,3711,565,9651,075,454

流动资产
货币资金931,950-6.93%1,001,3271,039,366651,463926,879
应收账款1,211,776-6.71%1,298,8791,410,5191,287,074837,177
存货188,0846.33%176,882173,536153,646105,493
其他流动资产22,465105.86%10,91333,47652,91873,039
2,354,275-5.37%2,488,0012,656,8972,145,1001,942,587

流动负债
短期借款161,323-13.68%186,889190,914109,2960
应付票据9380.00%9384,00017,8040
应付帐款6,91639.27%4,9663,12916,3386,058
其他流动负债236,959-36.57%373,577483,682468,270332,879
406,136-28.29%566,369681,725611,708338,937
流动资产净值1,948,1381.38%1,921,6321,975,1731,533,3921,603,650
资产总额减流动负债3,477,5310.47%3,461,2133,527,5433,099,3572,679,104

非流动负债
长期借款0--0015,7480
应付债券0--0000
其他非流动负债9,314-32.04%13,70513,4927,9418,804
9,314-32.04%13,70513,49223,6898,804

总权益
    实收股本132,9470.00%132,947134,650134,65090,000
    储备项目3,335,2700.62%3,314,5623,379,4012,941,0182,580,301
股东权益3,468,2170.60%3,447,5093,514,0523,075,6682,670,301
非控股权益0--0000